OCRHIPAA Privacy Rule

HIPAA Right of Access (45 CFR 164.524)

Individuals have a right to inspect and obtain copies of their PHI in a designated record set, in the form and format requested when readily producible, within 30 days.

Primary source

45 CFR 164.524 — eCFR

https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-C/part-164/subpart-E/section-164.524

Verified May 23, 2026 · This is the authoritative regulator URL. The summary below is a research aid; the linked source controls.

45 CFR 164.524 gives individuals the right to inspect and obtain a copy of PHI held in a designated record set. The standard requires action within 30 calendar days (a single 30-day extension is permitted with written notice), in the form and format the individual requests if readily producible, and at a fee limited to a reasonable, cost-based amount.

The OCR Right of Access Initiative has produced more than 50 enforcement actions since 2019, almost all for delays, denials, or excessive fees. Settlements have ranged from low five figures to over $200,000. The most common failure mode in cited cases is the 30-day deadline.

Practices must publish the request mechanism in the Notice of Privacy Practices, train workforce on intake, document the request and response date, and confirm transmission via the individual's chosen method (including unencrypted email if the individual has been warned of the risk and still elects it, per OCR guidance). Denials are limited to the narrow grounds in 164.524(a)(2)-(3).

Use this in your workspace

D3rx assembles the documentation linked to this regulation, walks the practical decisions in plain English, and stores the artifacts against the .gov sources cited above. It is an administrative research aid, not a substitute for counsel.

Related regulations

Authored by D3rx

D3rx is a healthcare-billing and compliance research aid maintained by D3rx Inc. Articles are drafted by an LLM (Anthropic Claude) against primary HHS, OCR, CMS, eCFR, NIST, and state-regulator publications, and reviewed for restraint and source fidelity by the D3rx team.

Reviewer status: a named credentialed reviewer (CHC, CHPC, or healthcare attorney) is being engaged. Until that engagement is finalized, this page does not claim credentialed review.

Last reviewed May 23, 2026 · Citation verified May 23, 2026

Research aid, not legal advice. This summary is an administrative research aid prepared by D3rx. It does not certify compliance, provide legal advice, replace counsel, or guarantee an audit outcome. For authoritative regulatory text follow the primary source link at the top of this page. The practice remains responsible for reviewing, adopting, and maintaining its compliance program.